Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ORF Genetics

Explore full profile

Plant-based recombinant protein solutions advancing biotech efficiency

Kópavogur, IcelandFounded 2001Biotech & Life Sciences
Valuation $10–25M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ORF Genetics and the history behind them.

About ORF Genetics

ORF Genetics is a pioneering company in the field of plant biotechnology, focusing on the production of recombinant proteins. Recombinant proteins are proteins that are genetically engineered in a lab for various uses, such as in medical research and treatments. ORF Genetics has developed a unique system that uses barley grains, grown in eco-friendly greenhouses, to produce these proteins. This method is both efficient and safe, making it a cost-effective solution for their clients.

The company serves a diverse range of clients, including researchers in stem cell technology, manufacturers of cell-cultured meat, and the skincare industry. For stem cell researchers, ORF Genetics provides endotoxin-free human growth factors and cytokines. Endotoxins are harmful substances that can contaminate lab results, so having endotoxin-free products is crucial for accurate research. In the cell-cultured meat industry, ORF offers a new generation of growth factors that help in the development of lab-grown meat. Additionally, the company has an award-winning line of plant-based anti-aging skincare products.

ORF Genetics operates in the biotechnology market, specifically focusing on plant-based solutions. Their business model revolves around leveraging their proprietary barley-based expression system to produce high-quality recombinant proteins. They generate revenue by selling these proteins to various industries, including medical research, food technology, and cosmetics.

In summary, ORF Genetics is a leader in using plant biotechnology to produce recombinant proteins efficiently and safely. They serve clients in stem cell research, cell-cultured meat production, and the skincare industry, making money by selling their innovative products.

Source: Dealroom company data

At a glance

Founded
2001
Headquarters
Kópavogur, Iceland
Sector
Biotech & Life Sciences

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Icelandic Centre for Research
  • Iceland Technology Development Fund
  • European Innovation Council
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇸 Iceland100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ORF Genetics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ORF Genetics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.